Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002038826-24-000001
Filing Date
2024-10-09
Accepted
2024-10-09 09:13:19
Documents
1
Effectiveness Date
2024-10-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6446
  Complete submission text file 0002038826-24-000001.txt   7542
Mailing Address 3262 WESTHEIMER ROAD SUITE 762 HOUSTON TX 77098
Business Address 3262 WESTHEIMER ROAD SUITE 762 HOUSTON TX 77098 617-834-3476
Bectas Therapeutics, Inc. (Filer) CIK: 0002038826 (see all company filings)

EIN.: 920728758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-526249 | Film No.: 241361626